In Vitro Susceptibility of Candida Species Isolated from Cancer Patients to Some Antifungal Agents
| LEADER | caa a22 4500 | ||
|---|---|---|---|
| 001 | 378911821 | ||
| 003 | CHVBK | ||
| 005 | 20180305123543.0 | ||
| 007 | cr unu---uuuuu | ||
| 008 | 161128e200406 xx s 000 0 eng | ||
| 024 | 7 | 0 | |a 10.1515/DMDI.2004.20.1-2.101 |2 doi |
| 035 | |a (NATIONALLICENCE)gruyter-10.1515/DMDI.2004.20.1-2.101 | ||
| 245 | 0 | 0 | |a In Vitro Susceptibility of Candida Species Isolated from Cancer Patients to Some Antifungal Agents |h [Elektronische Daten] |c [B. Özçelik,, S. Çıtak,, S. Cesur,, U. Abbasoglu,, F. Ιςlί,] |
| 540 | |a ©2011 by Walter de Gruyter GmbH & Co. | ||
| 700 | 1 | |a Özçelik, |D B. |4 aut | |
| 700 | 1 | |a Çıtak, |D S. |4 aut | |
| 700 | 1 | |a Cesur, |D S. |4 aut | |
| 700 | 1 | |a Abbasoglu, |D U. |4 aut | |
| 700 | 1 | |a Ιςlί, |D F. |4 aut | |
| 773 | 0 | |t Drug Metabolism and Drug Interactions |d De Gruyter |g 20/1-2(2004-06), 101-108 |x 0792-5077 |q 20:1-2<101 |1 2004 |2 20 |o DMDI | |
| 856 | 4 | 0 | |u https://doi.org/10.1515/DMDI.2004.20.1-2.101 |q text/html |z Onlinezugriff via DOI |
| 908 | |D 1 |a research article |2 jats | ||
| 950 | |B NATIONALLICENCE |P 856 |E 40 |u https://doi.org/10.1515/DMDI.2004.20.1-2.101 |q text/html |z Onlinezugriff via DOI | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Özçelik |D B. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Çıtak |D S. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Cesur |D S. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Abbasoglu |D U. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 700 |E 1- |a Ιςlί |D F. |4 aut | ||
| 950 | |B NATIONALLICENCE |P 773 |E 0- |t Drug Metabolism and Drug Interactions |d De Gruyter |g 20/1-2(2004-06), 101-108 |x 0792-5077 |q 20:1-2<101 |1 2004 |2 20 |o DMDI | ||
| 900 | 7 | |b CC0 |u http://creativecommons.org/publicdomain/zero/1.0 |2 nationallicence | |
| 898 | |a BK010053 |b XK010053 |c XK010000 | ||
| 949 | |B NATIONALLICENCE |F NATIONALLICENCE |b NL-gruyter | ||